Generex Biotechnology Corporation (GNBT)

Recent filings

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Introduction of Excellagen Aesthetics™ - Jan. 17, 2020

Generex Biotechnology Provides Investor Conference Call Details Tuesday January 21, 2020 at 9:30 AM - Jan. 17, 2020

Generex Biotechnology Provides 2019 Year-End Summary & 2020 Plans - Jan. 16, 2020

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday January 21, 2020 at 9:30 AM - Jan. 15, 2020

Generex Biotechnology Announces Interview with President & CEO Joe Moscato - Jan. 13, 2020

Generex Biotechnology Announces Update to Shareholder Stock Dividend - Jan. 10, 2020

Generex Biotechnology to be Featured at 2020 Wall Street Conference - Jan. 8, 2020

Departure of Directors or Certain - Jan. 7, 2020

Generex Biotechnology Announces Update to Shareholder Stock Dividend - Jan. 3, 2020

Generex Biotechnology Issues Shareholder Alert - Dec. 18, 2019

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 18 - Subsequent... - Dec. 16, 2019

General form for registration of securities under the Securities Act of 1933 - Dec. 12, 2019

OTCQB Certification - Dec. 11, 2019

Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors - Dec. 11, 2019

Generex Biotechnology Announces New Structure, Pay Date and Ex-Date for the Previously Postponed Shareholder Stock Dividend and Declares a New Share Dividend in NuGenerex Immuno-Oncology - Dec. 10, 2019

Generex Biotechnology Provides Update on Pending Dividend - Dec. 9, 2019

Generex Biotechnology Announces Funding Update - Dec. 5, 2019

Creek Mountain Partners, Inc. just provided an update on share ownership of Generex Biotechnology Corporation - Nov. 29, 2019

Reminder: Generex Investor Conference Call Friday, November 29, 2019 - Nov. 27, 2019

Generex Biotechnology Announces Postponement of Pending 1:1 Dividend - Nov. 27, 2019

Entry into a Material Definitive - Nov. 27, 2019

Generex Biotechnology Issues Shareholder Alert - Nov. 26, 2019

Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc. - Nov. 25, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Friday November 29, 2019 at 9:30 AM - Nov. 13, 2019

Generex Biotechnology Corporation Just Filed Its Annual Report: Net Income (Loss) pe... - Nov. 12, 2019

Generex Biotechnology Provides Guidance: Form 10k Annual Report will be filed Tuesday Morning November 12th 2019 - Nov. 8, 2019

Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells) - Nov. 5, 2019

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - Oct. 29, 2019

Submission of matters to a vote of Security - Oct. 29, 2019

Generex Biotechnology: 1 Stock Dividend - Oct. 29, 2019

Generex Biotechnology: 1 Stock Dividend - Oct. 29, 2019

Generex Biotechnology Announces Extension to the Pay Date for the Previously Declared 1:1 Stock Dividend - Oct. 29, 2019

Current report, item 8.01 - Oct. 29, 2019

Reminder: Generex Investor Conference Call Tomorrow October 29, 2019 - Oct. 28, 2019

Generex Announces Results of Annual Stockholders’ Meeting - Oct. 25, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 29, 2019 at 9:30 AM - Oct. 25, 2019

Generex Biotechnology Chief Medical & Scientific Officer Dr. Jason Terrell, MD is Awarded the 2019 Shepperd Pathfinder Award from the John Ben Shepperd Public Leadership Institute - Oct. 18, 2019

Generex Biotechnology Announces Merger with Public Vehicle for Public Trading of NuGenerex Immuno-Oncology - Oct. 15, 2019

Reminder: Generex Investor Conference Call Tomorrow October 15, 2019 - Oct. 14, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM - Oct. 1, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe - Oct. 1, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System - Sept. 30, 2019

Generex Biotechnology Announces Plans to Establish the NuGenerex Diabetes Research Center in Collaboration With Arizona Endocrinology Group & Paradise Valley Medical Family Medicine - Sept. 27, 2019

Generex Biotechnology Corporation releases salary data. CEO sees compensation fall -50% - Sept. 24, 2019

Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete - Sept. 20, 2019

Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (KeytrudaÒ) for the Treatment of Triple Negative Breast Cancer - Sept. 17, 2019

Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete - Sept. 16, 2019

Generex Biotechnology Announces Webcast and Invites All Shareholders to See and Listen to the Corporate Presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference - Sept. 12, 2019

Generex Biotechnology Corporation director just declared owning 3,568 shares of Generex Biotechnology Corporation - Sept. 11, 2019

Generex Biotechnology Signs Letters of Intent to Establish NuGenerex Health MSO with Arizona Endocrinology Center & Paradise Valley Family Medicine - Sept. 10, 2019

Generex Announces Date for Annual Shareholder Meeting and Pending Retirement of 20,375,900 GNBT “Pool Shares” - Sept. 6, 2019

Generex Announces Webcast - Sept. 5, 2019

Generex Biotechnology Confirms Record Date for 1:1 Dividend - Sept. 3, 2019

Generex Biotechnology Announces Time Slot for CEO Joe Moscato to Present at H.C. Wainwright Healthcare Conference - Aug. 26, 2019

Generex Biotechnology Reiterates 1:1 Stock Dividend for Clarity in the Market and Provides Details on Capital Structure - Aug. 23, 2019

Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50 - Aug. 19, 2019

Generex Biotechnology Announces Plans for NuGenerex Immuno-Oncology Spinout through a Targeted Acquisition of a Public Company and Planned Merger with Kiromic - Aug. 16, 2019

Generex Biotechnology Defines 1:1 Stock Dividend and Provides Details on Capital Structure - Aug. 15, 2019

Generex Biotechnology Announces Update to the Previously Declared 1:1 Stock Dividend - Aug. 12, 2019

Generex News Alert: Generex to Announce Positive Shareholder News on Monday August 12, 2019 at 8 AM Payment Details for the 1:1 GNBT Stock Dividend - Aug. 9, 2019

Generex Biotechnology Announces Interview with President & CEO Joe Moscato - Aug. 8, 2019

Generex Biotechnology Welcomes MediSource Partners to the NuGenerex Family of Companies - Aug. 1, 2019

Generex Biotechnology Introduces Pantheon Medical, the Newest Member of the NuGenerex Family of Companies - July 31, 2019

Generex Biotechnology Provides a Summary of Its Investor Conference Call Held on July 25, 2019 - July 26, 2019

Reminder: Investor Conference Call Today July 25, 2019 Management to Provide Details on Generex Up-list and 1:1 Stock Dividend - July 25, 2019

Generex Biotechnology Announces Satisfaction of Debt Obligation - July 19, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019 - July 16, 2019

Entry into a Material Definitive - July 16, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors APMA Annual Scientific Meeting - July 15, 2019

Generex Biotechnology Announces Closing on Acquisition of MediSource Partners - July 12, 2019

Generex Biotechnology Announces Acquisition of Pantheon Medical Foot & Ankle - July 11, 2019

Generex Biotechnology Provides Fiscal Year Overview - July 10, 2019

Generex Engages Donohoe Advisory to Assist with Uplisting - July 2, 2019

Generex Announces Update on 1:1 Dividend and NASDAQ Listing - June 28, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen Wound Conforming Matrix - June 26, 2019

Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company - June 25, 2019

Generex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward Plans - June 24, 2019

Generex Declares 1:1 Stock Dividend - June 20, 2019

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 16 - Subsequent... - June 19, 2019

Notification of inability to timely file Form 10-Q or 10-QSB - June 17, 2019

Reminder: Investor Conference Call Friday June 21st, 2019 - June 17, 2019

Generex Provides Update to Pending 1:1 Stock Dividend - June 7, 2019

Change In Registrants Certifying - June 5, 2019

Generex Biotechnology: Report Of Independent Auditor VENETO HOLDINGS, LLC TABLE OF CONTENTS REPORT OF INDEPENDENT AUDITOR CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2018 AND DECEMBER 31, - June 5, 2019

Generex Biotechnology CEO Joe Moscato To Present at H.C. Wainwright Healthcare Conference - June 4, 2019

Generex Biotechnology Announces Share Dividend & Strategic Plans - May 31, 2019

Generex Biotechnology Announces that its Subsidiary Olaregen Therapeutix Launches Excellagen at The Symposium on Advanced Wound Care (SAWC) in San Antonio, TX - May 16, 2019

Generex Biotechnology Announces Postponement of Its May 15th Investor Conference Call - May 15, 2019

Generex Biotechnology Corporation director just declared owning 320,345 shares of Generex Biotechnology Corporation - May 14, 2019

Generex Biotechnology Subsidiary NuGenerex Diagnostics Announces Sales for its Rapid Point-of-Care Malaria Diagnostic Test Kit - May 2, 2019

Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans - April 29, 2019

Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans - April 29, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C. - April 18, 2019

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 - Net Income ... - April 16, 2019

Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th - April 9, 2019

Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors - April 8, 2019

Departure of Directors or Certain - April 5, 2019

Entry into a Material Definitive - April 4, 2019

Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing - April 4, 2019

Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million - March 29, 2019

Sorry, no schedule available for this company

No known shareholders

Generex Biotechnology Corporation (GNBT)

140

cctranscripts

Jan. 17, 2020

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Introduction of Excellagen Aesthetics™ http://www.otcmarkets.com/stock/GNBT/news?id=251563

cctranscripts

Jan. 17, 2020

Generex Biotechnology Provides Investor Conference Call Details Tuesday January 21, 2020 at 9:30 AM http://www.otcmarkets.com/stock/GNBT/news?id=251589

cctranscripts

Jan. 16, 2020

Generex Biotechnology Provides 2019 Year-End Summary & 2020 Plans http://www.otcmarkets.com/stock/GNBT/news?id=251483

cctranscripts

Jan. 15, 2020

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday January 21, 2020 at 9:30 AM http://www.otcmarkets.com/stock/GNBT/news?id=251384

cctranscripts

Jan. 13, 2020

Generex Biotechnology Announces Interview with President & CEO Joe Moscato http://www.otcmarkets.com/stock/GNBT/news?id=251151

cctranscripts

Jan. 10, 2020

Generex Biotechnology Announces Update to Shareholder Stock Dividend http://www.otcmarkets.com/stock/GNBT/news?id=250974

cctranscripts

Jan. 8, 2020

Generex Biotechnology to be Featured at 2020 Wall Street Conference http://www.otcmarkets.com/stock/GNBT/news?id=250798

cctranscripts

Jan. 7, 2020

Departure of Directors or Certain http://www.conferencecalltranscripts.org/pink/summary?id=7261592

cctranscripts

Jan. 3, 2020

Generex Biotechnology Announces Update to Shareholder Stock Dividend http://www.otcmarkets.com/stock/GNBT/news?id=250427

cctranscripts

Dec. 18, 2019

Generex Biotechnology Issues Shareholder Alert http://www.otcmarkets.com/stock/GNBT/news?id=249658

cctranscripts

Dec. 16, 2019

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 18 - Subsequent... http://www.conferencecalltranscripts.org/pink/summary?id=7191448

cctranscripts

Dec. 12, 2019

General form for registration of securities under the Securities Act of 1933 http://www.conferencecalltranscripts.org/pink/summary?id=7179135

cctranscripts

Dec. 11, 2019

OTCQB Certification http://www.otcmarkets.com/financialReportViewer?symbol=GNBT&id=236996

cctranscripts

Dec. 11, 2019

Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors http://www.otcmarkets.com/stock/GNBT/news?id=249061

cctranscripts

Dec. 10, 2019

Generex Biotechnology Announces New Structure, Pay Date and Ex-Date for the Previously Postponed Shareholder Stock Dividend and Declares a New Share Dividend in NuGenerex Immuno-Oncology http://www.otcmarkets.com/stock/GNBT/news?id=248958

cctranscripts

Dec. 9, 2019

Generex Biotechnology Provides Update on Pending Dividend http://www.otcmarkets.com/stock/GNBT/news?id=248817

cctranscripts

Dec. 5, 2019

Generex Biotechnology Announces Funding Update http://www.otcmarkets.com/stock/GNBT/news?id=248553

cctranscripts

Nov. 29, 2019

Creek Mountain Partners, Inc. just provided an update on share ownership of Generex Biotechnology Corporation http://www.conferencecalltranscripts.org/pink/summary?id=7128821

cctranscripts

Nov. 27, 2019

Reminder: Generex Investor Conference Call Friday, November 29, 2019 http://www.otcmarkets.com/stock/GNBT/news?id=247740

cctranscripts

Nov. 27, 2019

Generex Biotechnology Announces Postponement of Pending 1:1 Dividend http://www.otcmarkets.com/stock/GNBT/news?id=247764
 


Feedback